CU Cancer Center member Ryan Ormond, MD, PhD, explains diagnosis and treatment of breast cancer that spreads to the brain.

Elahere, a new antibody-drug conjugate, shrank tumors in about a third of treatment-experienced patients.

NIH study finds therapeutic vaccine administered via IV infusion improves tumor-fighting T-cell action in mice.

People with a tendency to be active later in the day may be at greater risk for severe NAFLD.

The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels.

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Study results support the need for research into the value of monitoring these breast cancer patients with brain imaging tests.

Non-alcoholic fatty liver disease is substantially more common among men compared with women.

Gavin Ha explains his research on liquid biopsies—blood samples with traces of DNA that provide molecular details about cancer.

Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma.